AHK (Ala-His-Lys) vs AHK-Cu (Copper AHK)
Research material comparison: purity standards, available formats, molecular data, batch COA documentation, and regulatory status. For in vitro research use only.
| Attribute | AHK (Ala-His-Lys) | AHK-Cu (Copper AHK) |
|---|---|---|
| Category | Cosmetic / Research | Cosmetic / Research |
| Evidence Rating | D — Preclinical Only | D — Preclinical Only |
| Clinical Status | Research-only | Research-only |
| Mechanism | AHK chelates copper ions similarly to GHK. It stimulates dermal papilla cell proliferation via Wnt/beta-catenin pathway activation, promotes collagen synthesis, and enhances growth factor signaling for hair follicle enlargement. | Copper-dependent enzyme activation enhances dermal papilla cell stimulation. The copper complex promotes angiogenesis and ECM remodeling, with enhanced bioactivity compared to the non-copper form. |
| Half-Life | — | — |
| Bioavailability | — | — |
| Molecular Weight | — | — |
| WADA Status | Not Listed | Not Listed |
| Research Half-Life | — | — |
| Key Use Cases |
|
|
| Safety Concerns |
|
|
| Contraindications |
|
|
| Regulatory (US) | — | — |
Research Material Specifications
Catalog specifications for the corresponding research materials, including batch documentation coverage.
| Specification | AHK (Ala-His-Lys) | AHK-Cu (Copper AHK) |
|---|---|---|
| Purity Standard | ≥98% | ≥98% |
| CAS Number | N/A | N/A |
| Molecular Formula | N/A | N/A |
| Available Formats | 100mg | 100mg |
| Batch COAs Published | — | — |
| Stock Status | Out of stock | Out of stock |
Availability at Volta Peptides
Research Disclaimer: This comparison is provided for educational purposes only. All products are sold exclusively for in vitro research use. The information presented is based on published preclinical and clinical research and does not constitute medical advice. Consult a qualified healthcare professional before making any decisions regarding peptide use.
Explore More
Comparisons
Compare any two peptides side-by-side or browse our curated popular matchups.